Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FP7AS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,881
Award facts
- Contract value 100% obligated
- $3,881.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,881.10 for 200-unit vials of Botox by the Defense Logistics Agency (DLA) on September 23, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 15, 2025, is issued under DMS's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026. The contract carries no specific set-aside designation, allowing DMS to compete on its merits as a woman-owned small business in federal procurement.
This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense healthcare facilities. The company's core business involves distributing branded and generic prescription drugs, biologics, and medical supplies to military and federal healthcare systems nationwide. Botox, a widely-used pharmaceutical product in medical settings, will be delivered to the Park Ridge, Illinois location for distribution to support medical supply needs across DLA-serviced facilities. This award reflects DMS's consistent ability to secure pharmaceutical contracts with federal agencies and its position as a reliable provider of specialized medical products to the defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FP7AS?
SPE2DB25FP7AS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FP7AS worth?
The government has obligated $3,881 on SPE2DB25FP7AS.
Is contract SPE2DB25FP7AS an order under another contract?
Yes. SPE2DB25FP7AS is a delivery order under SPE2DB22D9311, an indefinite delivery contract.
Was contract SPE2DB25FP7AS competed?
The extent of competition for SPE2DB25FP7AS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award